1. Home
  2. PCRX vs AVXL Comparison

PCRX vs AVXL Comparison

Compare PCRX & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • AVXL
  • Stock Information
  • Founded
  • PCRX 2006
  • AVXL 2004
  • Country
  • PCRX United States
  • AVXL United States
  • Employees
  • PCRX N/A
  • AVXL N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PCRX Health Care
  • AVXL Health Care
  • Exchange
  • PCRX Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • PCRX 604.7M
  • AVXL 716.1M
  • IPO Year
  • PCRX 2011
  • AVXL N/A
  • Fundamental
  • Price
  • PCRX $18.98
  • AVXL $8.63
  • Analyst Decision
  • PCRX Buy
  • AVXL Strong Buy
  • Analyst Count
  • PCRX 10
  • AVXL 2
  • Target Price
  • PCRX $26.60
  • AVXL $43.00
  • AVG Volume (30 Days)
  • PCRX 933.0K
  • AVXL 1.5M
  • Earning Date
  • PCRX 11-06-2024
  • AVXL 02-05-2025
  • Dividend Yield
  • PCRX N/A
  • AVXL N/A
  • EPS Growth
  • PCRX N/A
  • AVXL N/A
  • EPS
  • PCRX N/A
  • AVXL N/A
  • Revenue
  • PCRX $694,957,000.00
  • AVXL N/A
  • Revenue This Year
  • PCRX $4.94
  • AVXL N/A
  • Revenue Next Year
  • PCRX N/A
  • AVXL N/A
  • P/E Ratio
  • PCRX N/A
  • AVXL N/A
  • Revenue Growth
  • PCRX 4.40
  • AVXL N/A
  • 52 Week Low
  • PCRX $11.16
  • AVXL $3.25
  • 52 Week High
  • PCRX $35.95
  • AVXL $10.45
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 54.07
  • AVXL 53.18
  • Support Level
  • PCRX $18.73
  • AVXL $7.93
  • Resistance Level
  • PCRX $20.34
  • AVXL $9.48
  • Average True Range (ATR)
  • PCRX 1.13
  • AVXL 0.66
  • MACD
  • PCRX -0.03
  • AVXL -0.07
  • Stochastic Oscillator
  • PCRX 64.09
  • AVXL 55.03

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

Share on Social Networks: